Top

Published in:

01-03-2012 | Thoracic Oncology

Staging of Regional Nodes in Pulmonary Malignancies

Authors: Mark B. Faries, MD, Donald L. Morton, MD, FACS

Published in: Annals of Surgical Oncology | Issue 3/2012

Excerpt

The role of lymphadenectomy in the surgical management of primary lung cancer is controversial. More than half of patients with apparently node-negative non-small cell lung cancer (NSCLC) will die of metastases within 5 years.1 Some of this mortality may be due to direct hematogenous dissemination, but much may reflect surgical and/or pathologic approaches that fail to identify tumor-containing nodes. …

SEER. SEER Cancer Statistics Review. Lung and bronchus, 1975–2000. http://seer.cancer.gov/csr/1975_2000/sections.html

Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg. 1998;227:138–44.PubMedCrossRef

Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290–4.PubMedCrossRef

Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1–6.PubMedCrossRef

Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev. 2005;(1):CD004699.

Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9.PubMedCrossRef

Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):234S–42S.PubMedCrossRef

Chen Z, Perez S, Holmes E, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst. 1993;85:493–8.PubMedCrossRef

Gu C, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg. 2002;235:133–9.PubMedCrossRef

10.

Kubuschok B, Passlick B, Izbicki JR, et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol. 1999;17:19–24.PubMed

11.

Marchevsky AM, Gupta R, Kusuanco D, et al. The presence of isolated tumor cells and micrometastases in the intrathoracic lymph nodes of patients with lung cancer is not associated with decreased survival. Hum Pathol. 2010;41:1536–43.PubMedCrossRef

12.

Iddings D, Bilchik A. The biologic significance of micrometastatic disease and sentinel lymph node technology on colorectal cancer. J Surg Oncol. 2007;96:671–7.PubMedCrossRef

13.

Benlloch S, Galbis-Caravajal JM, Alenda C, et al. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases. Ann Oncol. 2009;20:91–7.PubMedCrossRef

14.

Hashimoto T, Kobayashi Y, Ishikawa Y, et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res. 2000;60:6472–8.PubMed

15.

Goldstein N, Mani A, Chmielewski G, et al. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol. 2000;241:274–9.CrossRef

16.

Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or observation in melanoma. N Engl J Med. 2006;355:1307–17.PubMedCrossRef

17.

Little A, DeHoyos A, Kirgan D, et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg. 1999;117:220–34.PubMedCrossRef

18.

Liptay M, Masters G, Winchester D, et al. Intraoperative radioisotope sentinel node mapping in non-small cell lung cancer. Ann Thor Surg. 2000;70:384–9.CrossRef

19.

Faries MB, Bleicher RJ, Ye X, et al. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg. 2004;139:870–6.PubMedCrossRef

20.

Liptay MJ, D’Amico T A, Nwogu C, et al. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol. 2009;4:198–202.PubMedCrossRef

21.

Bustos ME, Camargo JJ, Resin Geyer G, et al. Intraoperative detection of sentinel lymph nodes using Patent Blue V in non-small cell lung cancer. Minerva Chir. 2008;63:29–36.PubMed

22.

Rzyman W, Hagen OM, Dziadziuszko R, et al. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer. Eur J Surg Oncol. 2006;32:462–5.PubMedCrossRef

23.

Ito N, Fukuta M, Tokushima T, et al. Sentinel node navigation surgery using indocyanine green in patients with lung cancer. Surg Today. 2004;34:581–5.PubMed

24.

Melfi FM, Lucchi M, Davini F, et al. Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction. Eur J Cardiothorac Surg. 2008;34:181–6.PubMedCrossRef

25.

Nomori H, Horio H, Naruke T, et al. Use of technetium-99 m tin colloid for sentinel lymph node identification in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;124:486–92.PubMedCrossRef

26.

Nomori H, Ohba Y, Yoshimoto K, et al. Difference of sentinel lymph node identification between tin colloid and phytate in patients with non-small cell lung cancer. Ann Thorac Surg. 2009;87:906–10.PubMedCrossRef

27.

Minamiya Y, Ito M, Katayose Y, et al. Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer. Ann Thorac Surg. 2006;81:327–30.PubMedCrossRef

28.

Lardinois D, Brack T, Gaspert A, et al. Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer. Eur J Cardiothorac Surg. 2003;23:824–7.PubMedCrossRef

29.

Yamashita S, Tokuishi K, Miyawaki M, et al. Sentinel node navigation surgery by thoracoscopic fluorescence imaging system and molecular examination in non-small cell lung cancer. Ann Surg Oncol. doi:10.1245/s10434-011-2145-x.

30.

Takeuchi H, Morton DL, Kuo C, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol. 2004;22:2671–80.PubMedCrossRef

Title: Staging of Regional Nodes in Pulmonary Malignancies
Authors: Mark B. Faries, MD
Donald L. Morton, MD, FACS
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 3/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-2146-9

At a glance: The STEP trials

Springer Medicine

Staging of Regional Nodes in Pulmonary Malignancies

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas

Anterior-entry Abdominoperineal Resection: A Variation in the Method of Perineal Dissection

Influence of Surgical Volume on Outcome for Laparoscopic Hysterectomy for Endometrial Cancer

Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study

Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Oncology Health Information Quality on the Internet: a Multilingual Evaluation